tiprankstipranks
Trending News
More News >
Silex Systems Limited (AU:SLX)
ASX:SLX

Silex Systems Limited (SLX) AI Stock Analysis

Compare
75 Followers

Top Page

AU:SLX

Silex Systems Limited

(Sydney:SLX)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
AU$6.00
▼(-13.04% Downside)
Action:ReiteratedDate:01/07/26
The score is primarily held down by weak financial performance (sharp revenue contraction, ongoing losses, and declining free cash flow). Technical signals also remain bearish with the price below key moving averages and a negative MACD, while valuation is constrained by loss-making results (negative P/E) and no dividend data.
Positive Factors
Low leverage
A low debt-to-equity ratio provides durable financial flexibility and lowers bankruptcy risk. Over the next 2–6 months this limited leverage supports the company's ability to fund operations or R&D without excessive interest burden, preserving optionality during recovery periods.
Cash conversion ability
A positive operating cash flow to net income ratio shows core operations generate cash relative to accounting profits. This sustainable cash conversion helps fund working capital and product development, reducing reliance on external financing during cyclical industry phases.
Stable equity base
A stable equity ratio signals a resilient asset base that can underpin operations and future investment. Over the medium term, this supports creditor confidence and gives management room to prioritize strategic projects or absorb near-term shocks without immediate capital raises.
Negative Factors
Revenue contraction
A steep revenue decline of ~44% is a structural concern: it erodes economies of scale, pressures gross margins, and constrains reinvestment capacity. Without clear recovery drivers, persistent top-line shrinkage undermines medium-term profitability and strategic initiatives.
Ongoing losses & margins
Sustained negative net profit and EBIT margins indicate the business currently can't cover operating costs from revenues. Over months this reduces retained earnings, limits capital for growth, and raises the bar for turnaround, pressuring stakeholder support and strategic options.
Declining free cash flow
A near 40% decline in free cash flow growth weakens the company’s ability to self-fund capex, R&D, and working capital. Over the medium term this increases reliance on external funding, constrains strategic flexibility, and heightens execution risk during industry cycles.

Silex Systems Limited (SLX) vs. iShares MSCI Australia ETF (EWA)

Silex Systems Limited Business Overview & Revenue Model

Company DescriptionSilex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also develops cREO, a semiconductor technology. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
How the Company Makes MoneySilex Systems Limited generates revenue primarily through the licensing of its proprietary SILEX technology, which is used for uranium enrichment. The company earns fees from licensing agreements with partners in the nuclear sector, as well as from sales of enriched uranium products. Key revenue streams include upfront licensing fees, ongoing royalties based on uranium production, and potential sales of nuclear fuel to energy companies. Additionally, SLX has formed strategic partnerships with major players in the nuclear industry, which not only enhances its credibility but also opens up further revenue opportunities through collaborative projects and joint ventures.

Silex Systems Limited Financial Statement Overview

Summary
Overall financials indicate significant strain: steep revenue decline (-44.35%) and persistent losses (negative net profit and EBIT margins). Low leverage is a positive, but negative ROE and weakening free cash flow growth (-39.62%) keep the score low.
Income Statement
30
Negative
Silex Systems Limited has experienced significant revenue decline, with a negative revenue growth rate of -44.35% in the most recent year. The company is facing substantial losses, as indicated by negative net profit and EBIT margins. These factors suggest challenges in maintaining profitability and growth.
Balance Sheet
45
Neutral
The company's balance sheet shows a low debt-to-equity ratio, indicating limited leverage, which is a positive aspect. However, the return on equity is negative, reflecting ongoing losses and challenges in generating shareholder value. The equity ratio remains stable, suggesting a solid asset base relative to equity.
Cash Flow
40
Negative
Silex Systems Limited has seen a decline in free cash flow growth, with a negative growth rate of -39.62%. The operating cash flow to net income ratio is positive, indicating some ability to convert income into cash. However, the overall cash flow position remains weak due to ongoing losses.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue13.72M6.79M6.11M6.84M4.22M1.92M
Gross Profit315.25K6.79M-5.09M-1.98M-2.86M-4.42M
EBITDA-3.46M-41.97M-22.27M-5.53M-9.00M-6.61M
Net Income-42.44M-42.56M-22.73M-17.36M-9.46M-6.93M
Balance Sheet
Total Assets224.76M98.96M141.56M152.20M54.12M24.04M
Cash, Cash Equivalents and Short-Term Investments202.41M81.96M117.00M140.74M46.53M19.90M
Total Debt1.24M910.20K1.18M772.14K982.50K38.40K
Total Liabilities7.37M8.01M9.62M3.51M3.57M1.97M
Stockholders Equity217.39M90.95M131.94M148.69M50.55M22.07M
Cash Flow
Free Cash Flow8.32M2.86M5.85M-2.43M287.28K-4.96M
Operating Cash Flow8.41M3.02M6.14M-2.34M412.64K-4.78M
Investing Cash Flow-164.37M-2.61M7.56M-114.40M-40.06M9.79M
Financing Cash Flow143.61M403.06K2.34M114.55M38.20M-199.34K

Silex Systems Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.90
Price Trends
50DMA
7.22
Negative
100DMA
7.88
Negative
200DMA
6.06
Positive
Market Momentum
MACD
-0.06
Negative
RSI
48.75
Neutral
STOCH
60.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SLX, the sentiment is Negative. The current price of 6.9 is above the 20-day moving average (MA) of 6.83, below the 50-day MA of 7.22, and above the 200-day MA of 6.06, indicating a neutral trend. The MACD of -0.06 indicates Negative momentum. The RSI at 48.75 is Neutral, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SLX.

Silex Systems Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
AU$932.46M23.8565.33%10.16%25.67%744.90%
68
Neutral
AU$464.65M18.238.20%1.06%-30.96%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
AU$1.05B-22.87-50.48%333.23%10.83%
56
Neutral
AU$641.06M52.04-3.19%0.40%-280.65%
45
Neutral
AU$25.29M-0.34-121.41%-1034.67%
41
Neutral
AU$1.92B-40.54-37.20%5.81%-86.09%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:SLX
Silex Systems Limited
6.90
2.72
65.07%
AU:WIN
Widgie Nickel Limited
0.03
0.01
61.11%
AU:BVS
Bravura Solutions Limited
2.08
-0.21
-9.21%
AU:TYR
Tyro Payments Ltd.
0.88
0.03
2.94%
AU:WBT
Weebit Nano Ltd.
4.98
2.85
133.80%
AU:NXL
Nuix Ltd.
1.92
-1.65
-46.36%

Silex Systems Limited Corporate Events

Silex Hits Key Readiness Milestone as U.S. Laser Enrichment Plans Advance
Feb 24, 2026

Silex Systems reported that its SILEX laser uranium enrichment technology, developed with Global Laser Enrichment, has reached Technology Readiness Level 6 following large-scale demonstration at GLE’s integrated pilot plant in Wilmington, North Carolina. This milestone significantly reduces technology risk and supports the transition toward full-scale design and planning for the proposed Paducah Laser Enrichment Facility in Kentucky.

The company highlighted that GLE’s Paducah project could become a key single-site hub for uranium production, conversion, and enrichment in the U.S., leveraging exclusive access to over 200,000 metric tonnes of depleted tails from the Department of Energy. Progress during the half year included U.S. Nuclear Regulatory Commission acceptance of the Paducah licence application, expansion of classified manufacturing in Wilmington, preliminary site work, and a US$28.5 million DOE funding award, reinforcing GLE’s competitive position against centrifuge-based rivals.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Boosts Cash Reserves as Revenue Doubles but Loss Persists
Feb 24, 2026

Silex Systems reported a sharp improvement in liquidity for the half-year ended 31 December 2025, with cash, term deposits and dual currency term deposits rising 150.4% to about $201.7 million from June 2025. Revenue from ordinary activities more than doubled year-on-year to $14.2 million, while the net loss attributable to members narrowed slightly to $17.9 million, and the company did not declare a dividend.

The results underscore Silex’s continued investment in commercialising its SILEX laser enrichment technology across uranium, quantum computing materials and medical isotopes. With its uranium enrichment venture Global Laser Enrichment jointly controlled with Cameco Corporation, Silex is positioning itself as a key contributor to secure nuclear fuel supply and emerging high-tech markets, despite remaining loss-making during the period.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems to Release 395,507 Shares From Voluntary Escrow
Feb 10, 2026

Silex Systems Limited has announced that 395,507 fully paid ordinary shares will be released from voluntary escrow on 27 February 2026. The move increases the number of tradeable shares on the market and may enhance liquidity for existing and prospective shareholders, though it does not in itself alter the company’s underlying operations or strategy.

The release is being made in accordance with ASX Listing Rule 3.10A and has been authorised by the company’s CFO and Company Secretary. Investors are directed to the company’s website and investor relations channel for further information about Silex’s ongoing activities and any subsequent implications for capital management or ownership structure.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$6.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex-Backed GLE Wins US DOE Innovation Funding for Laser Uranium Enrichment
Jan 5, 2026

Global Laser Enrichment, the exclusive licensee of Silex Systems’ SILEX uranium enrichment technology, has been selected by the U.S. Department of Energy for an Innovative Technology Award of up to US$28 million to advance next-generation laser-based uranium enrichment, though it missed out on a separate US$900 million Low Enriched Uranium supply award. GLE reaffirmed its strategy to progress the planned Paducah Laser Enrichment Facility, including re-enriching DOE high-assay depleted uranium tails to significantly boost U.S. domestic uranium and conversion supply, continue NRC licensing efforts, and deepen engagement with industry partners, positioning the SILEX technology as a potentially major future contributor to global nuclear fuel production and U.S. energy security.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Updates Substantial Holding Changes
Dec 18, 2025

Silex Systems Limited has reported changes in substantial holdings involving its securities. The announcement outlines specific updates to relevant interests and associations, impacting the voting rights and investment management structure. The changes signify a shift in the position of a major stakeholder, which could influence the company’s governance dynamics and potentially affect shareholder relations.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Announces Change in Director’s Securities Holdings
Dec 17, 2025

Silex Systems Limited has issued a detailed report concerning updates on its director Michael Goldsworthy’s interest in company securities, highlighting the exercise of options and vesting of performance rights under its Employee Incentive Plan. The transactions, tied to meeting key performance milestones like the successful demonstration of its SILEX uranium enrichment technology, underscore the company’s progress in advancing its proprietary technology and its focus on long-term stakeholder value.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Expands Market Presence with New Securities Quotation
Dec 15, 2025

Silex Systems Limited announced the quotation of 562,500 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 15, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional value to its stakeholders by leveraging new opportunities in the securities market.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

State Street Ceases Substantial Holding in Silex Systems
Dec 4, 2025

Silex Systems Limited has announced that State Street Corporation and its subsidiaries, including State Street Global Advisors, have ceased to be substantial holders in the company as of December 2, 2025. This change in substantial holding may impact the company’s shareholder structure and influence its market dynamics, as State Street’s involvement in the company has been significant.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Expands Market Presence with New Securities Issuance
Dec 4, 2025

Silex Systems Limited has announced the issuance of 31,000 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code SLX. This move is part of the company’s strategy to enhance its financial position and support its ongoing projects, potentially impacting its market presence and offering new opportunities for stakeholders.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited Announces Change in Substantial Holding
Dec 2, 2025

Silex Systems Limited has announced a change in substantial holding, indicating that a previous substantial holder has ceased to hold a significant interest in the company as of November 28, 2025. This change in holding may impact the company’s shareholder structure and could influence voting dynamics and future corporate decisions.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 07, 2026